$PMCB 4 SEC Filings

Filed On	Filing
02 Apr 2026	Form 4: Weinstein Robert, Director Granted 119,170 Stock Option (Right to Buy)
02 Apr 2026	Form 4: Walker Wayne Remell, Director Granted 119,170 Stock Option (Right to Buy)
02 Apr 2026	Form 4: Schechter Jonathan, Director Granted 119,170 Stock Option (Right to Buy)
02 Apr 2026	Form 4: Abecassis Michael M, Director Granted 119,170 Stock Option (Right to Buy)
18 Mar 2026	Form 4: PharmaCyte Biotech, Inc., 10% owner · Femasys Inc
07 Jan 2026	Form 4: Silverman Joshua, Director Bought 30,000 shares ($23.5K) · Bought 30,000 shares ($23.7K) · Bought 40,000 shares ($33.3K)
07 Jan 2026	Form 4: Schechter Jonathan, Director Bought 20,000 shares ($15.6K) · Bought 20,000 shares ($15.8K) · Bought 20,000 shares ($16.9K)
12 Dec 2025	Form 4: Weinstein Robert, Director Granted 63,233 Stock Option (Right to Buy) · Received 75,000 shares as a grant or award · Gave up 33,750 shares to cover exercise price or tax ($34.4K)
12 Dec 2025	Form 4: Walker Wayne Remell, Director Granted 63,233 Stock Option (Right to Buy) · Received 37,500 shares as a grant or award · Gave up 16,875 shares to cover exercise price or tax ($17.2K)
12 Dec 2025	Form 4: Silverman Joshua, Director Received 575,000 shares as a grant or award · Gave up 258,750 shares to cover exercise price or tax ($264K)
12 Dec 2025	Form 4: Schechter Jonathan, Director Granted 63,233 Stock Option (Right to Buy) · Received 150,000 shares as a grant or award · Gave up 67,500 shares to cover exercise price or tax ($68.9K)
12 Dec 2025	Form 4: Abecassis Michael M, Director Granted 63,233 Stock Option (Right to Buy) · Received 37,500 shares as a grant or award · Gave up 16,875 shares to cover exercise price or tax ($17.2K)
18 Nov 2025	Form 4: PharmaCyte Biotech, Inc., 10% owner · Q/C Technologies Inc Acquired 889,865 Series H Convertible Preferred Stock (Open Market Purchase) · Acquired 889,865 Warrants (Open Market Purchase)
17 Jul 2024	Form 4: Weinstein Robert, Director Granted 38,009 Stock Option (Right to Buy)
17 Jul 2024	Form 4: Walker Wayne Remell, Director Granted 38,009 Stock Option (Right to Buy)
17 Jul 2024	Form 4: Schechter Jonathan, Director Granted 38,009 Stock Option (Right to Buy)
17 Jul 2024	Form 4: Abecassis Michael M, Director Granted 38,009 Stock Option (Right to Buy)
22 Nov 2023	Form 4: Weinstein Robert, Director Granted 61,248 Stock Option (Right to Buy)
22 Nov 2023	Form 4: Walker Wayne Remell, Director Granted 61,248 Stock Option (Right to Buy)
22 Nov 2023	Form 4: Trujillo Carlos, Director Granted 85,000 Stock Option (Right to Buy)

Comments